Ranbaxy continues to supply the developing world with drugs that are not checked for quality.

Ranbaxy continues to supply the developing world with drugs that are not checked for quality.

India's major pharmaceutical companies and its public health community want to establish a modern drug regulatory system.

The WHO must work with the United States to deliver useful AIDS drugs in a controlled and responsible way to ensure that patients really do get better.

The strategy of fighting AIDS in Africa with questionable generic drugs made in developing countries now lies in shambles.

India has enormous potential for drug development if its legal system will respect intellectual property.

Ranbaxy's run-in with the FDA illustrates problems in developing-world drug production, but is there a place for less stringent quality standards?

If patent laws are thrown out in India's high court, it could jeopardize the world's patent system.